$PHCI
Panamera Holdings Corp

2022 Q4 Form 10-K Financial Statement

#000164033423000027 Filed on January 06, 2023

View on sec.gov

Income Statement

Concept 2022 Q4 2022 Q3 2022
Revenue $25.00K $25.00K $41.67K
YoY Change
Cost Of Revenue $22.89K $38.21K $38.21K
YoY Change
Gross Profit $2.107K -$13.21K $3.452K
YoY Change
Gross Profit Margin 8.43% -52.84% 8.28%
Selling, General & Admin $5.500K $4.950K $35.95K
YoY Change 125.41% -92.95% -60.06%
% of Gross Profit 261.03% 1041.43%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $5.495K -$9.000K $35.95K
YoY Change 125.2% -112.82% -60.38%
Operating Profit -$3.388K -$4.210K -$32.50K
YoY Change 38.85% -64.18%
Interest Expense $833.00 -$600.00 $1.542K
YoY Change 1143.28% 100.0% -66.5%
% of Operating Profit
Other Income/Expense, Net $833.00 $1.542K
YoY Change 1143.28% -133.5%
Pretax Income -$4.221K -$4.810K -$34.04K
YoY Change 68.37% -93.18% -64.3%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$4.221K -$4.810K -$34.04K
YoY Change 68.37% -93.18% -64.3%
Net Earnings / Revenue -16.88% -19.24% -81.71%
Basic Earnings Per Share
Diluted Earnings Per Share $0.00 $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 33.21M shares
Diluted Shares Outstanding 39.21M shares

Balance Sheet

Concept 2022 Q4 2022 Q3 2022
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.970K $3.090K $3.090K
YoY Change 29600.0% 30800.0%
Cash & Equivalents $2.967K $3.087K
Short-Term Investments
Other Short-Term Assets $60.00 $60.00 $60.00
YoY Change
Inventory
Prepaid Expenses $55.00 $55.00
Receivables $8.330K $8.330K $8.330K
Other Receivables $1.500K $1.100K $1.100K
Total Short-Term Assets $12.85K $12.57K $12.57K
YoY Change 116745.45% 125620.0%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00 $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $12.85K $12.57K $12.57K
Total Long-Term Assets $0.00 $0.00 $0.00
Total Assets $12.85K $12.57K $12.57K
YoY Change 116745.45% 125620.0%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $18.28K $17.03K $17.03K
YoY Change 51.31% 26.05% 70.3%
Accrued Expenses $7.630K $7.710K $7.710K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $37.95K $33.95K $33.95K
YoY Change 592.52% 2008.7%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $63.86K $60.19K $60.19K
YoY Change 263.58% 298.0% 200.95%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $63.86K $60.19K $60.19K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $63.86K $60.19K $60.19K
YoY Change 263.58% 298.0% 200.95%
SHAREHOLDERS EQUITY
Retained Earnings -$402.3K -$398.0K
YoY Change 9.76% 9.35%
Common Stock $3.921K $350.4K
YoY Change 0.0% 8837.16%
Preferred Stock
YoY Change
Treasury Stock (at cost) $600.00
YoY Change
Treasury Stock Shares
Shareholders Equity -$51.00K -$47.61K -$47.61K
YoY Change
Total Liabilities & Shareholders Equity $12.85K $12.57K $12.57K
YoY Change 116745.45% 125620.0%

Cashflow Statement

Concept 2022 Q4 2022 Q3 2022
OPERATING ACTIVITIES
Net Income -$4.221K -$4.810K -$34.04K
YoY Change 68.37% -93.18% -64.3%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$4.120K -$6.090K -$29.26K
YoY Change 6.35% -92.68% -70.55%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00
YoY Change -100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $4.000K 5.000K $32.34K
YoY Change 3.23% -93.98% -66.71%
NET CHANGE
Cash From Operating Activities -$4.120K -6.090K -$29.26K
Cash From Investing Activities
Cash From Financing Activities $4.000K 5.000K $32.34K
Net Change In Cash -$120.00 -1.090K $3.077K
YoY Change -12100.0% 626.67% -238.48%
FREE CASH FLOW
Cash From Operating Activities -$4.120K -$6.090K -$29.26K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022 us-gaap Operating Expenses
OperatingExpenses
35954 usd
CY2021 us-gaap Operating Expenses
OperatingExpenses
90749 usd
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-90749 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-47614 usd
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022 dei Entity Central Index Key
EntityCentralIndexKey
0001620749
CY2022 dei Amendment Flag
AmendmentFlag
false
CY2022 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--07-31
CY2022 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2022 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2021Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2021Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
550000000 shares
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
39210000 shares
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
39210000 shares
CY2021Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
39210000 shares
CY2021Q3 us-gaap Preferred Stock Discount On Shares
PreferredStockDiscountOnShares
50000000 usd
CY2021Q3 us-gaap Preferred Stock No Par Value
PreferredStockNoParValue
0.0001
CY2021Q3 pnht Common Stock Shares Authorized1
CommonStockSharesAuthorized1
150000000 shares
CY2021Q3 pnht Common Stock Par Value
CommonStockParValue
0.0001
CY2022 dei Document Type
DocumentType
10-K
CY2022 dei Document Annual Report
DocumentAnnualReport
true
CY2022 dei Document Period End Date
DocumentPeriodEndDate
2022-07-31
CY2022 dei Document Transition Report
DocumentTransitionReport
false
CY2022 dei Entity File Number
EntityFileNumber
000-55569
CY2022 dei Entity Registrant Name
EntityRegistrantName
PANAMERA HOLDINGS CORPORATION
CY2022 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2022 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
46-5707326
CY2022 dei Entity Address Address Line1
EntityAddressAddressLine1
1218 Webster Street
CY2022 dei Entity Address City Or Town
EntityAddressCityOrTown
Houston
CY2022 dei Entity Address State Or Province
EntityAddressStateOrProvince
TX
CY2022 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
77002
CY2022 dei City Area Code
CityAreaCode
713
CY2022 dei Local Phone Number
LocalPhoneNumber
289-6200
CY2022 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2022 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2022 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022 dei Entity Small Business
EntitySmallBusiness
true
CY2022 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2022 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2022 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2022 dei Entity Shell Company
EntityShellCompany
true
CY2022Q1 dei Entity Public Float
EntityPublicFloat
20475000 usd
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
33210000 shares
CY2022 dei Auditor Firm
AuditorFirmId
2738
CY2022 dei Auditor Name
AuditorName
M&K CPAS, PLLC
CY2022 dei Auditor Location
AuditorLocation
Houston, TX
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3087 usd
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
10 usd
CY2022Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
17034 usd
CY2021Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
13514 usd
CY2022Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
346505 usd
CY2021Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
344963 usd
CY2022 us-gaap Revenue From Related Parties
RevenueFromRelatedParties
41666 usd
CY2021 us-gaap Revenue From Related Parties
RevenueFromRelatedParties
0 usd
CY2022 us-gaap Cost Of Revenue
CostOfRevenue
38214 usd
CY2021 us-gaap Cost Of Revenue
CostOfRevenue
0 usd
CY2022 us-gaap Gross Profit
GrossProfit
3452 usd
CY2021 us-gaap Gross Profit
GrossProfit
0 usd
CY2022 us-gaap Professional Fees
ProfessionalFees
22953 usd
CY2021 us-gaap Professional Fees
ProfessionalFees
86450 usd
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
13001 usd
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4299 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-32502 usd
CY2022 us-gaap Interest Expense
InterestExpense
1542 usd
CY2021 us-gaap Interest Expense
InterestExpense
4603 usd
CY2022 us-gaap Other Expenses
OtherExpenses
1542 usd
CY2021 us-gaap Other Expenses
OtherExpenses
4603 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-34044 usd
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-95352 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-34044 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-95352 usd
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
39210000 shares
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
23571151 shares
CY2021 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
201335 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-95352 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-15112 usd
CY2022 pnht Imputed Interest On Related Party Loan
ImputedInterestOnRelatedPartyLoan
1542 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-34044 usd
CY2022 us-gaap Interest Income Related Party
InterestIncomeRelatedParty
1542 usd
CY2021 us-gaap Interest Income Related Party
InterestIncomeRelatedParty
0 usd
CY2022 us-gaap Increase Decrease In Other Accounts Payable
IncreaseDecreaseInOtherAccountsPayable
3520 usd
CY2021 us-gaap Increase Decrease In Other Accounts Payable
IncreaseDecreaseInOtherAccountsPayable
7032 usd
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-8332 usd
CY2021 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
0 usd
CY2022 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
55 usd
CY2021 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
0 usd
CY2022 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-1098 usd
CY2022 us-gaap Increase Decrease In Deferred Revenue And Customer Advances And Deposits
IncreaseDecreaseInDeferredRevenueAndCustomerAdvancesAndDeposits
1500 usd
CY2022 pnht Payroll Liabilities Related Party
PayrollLiabilitiesRelatedParty
7706 usd
CY2021 pnht Payroll Liabilities Related Party
PayrollLiabilitiesRelatedParty
0 usd
CY2022 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
0 usd
CY2021 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-11044 usd
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-99364 usd
CY2021 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
15858 usd
CY2022 pnht Payment To Fund Longterm Loans To Related Parties
PaymentToFundLongtermLoansToRelatedParties
0 usd
CY2021 pnht Payment To Fund Longterm Loans To Related Parties
PaymentToFundLongtermLoansToRelatedParties
120051 usd
CY2022 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 usd
CY2021 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
201335 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
32338 usd
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
97142 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
3077 usd
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-2222 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
10 usd
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2232 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3087 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
10 usd
CY2022 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2021 us-gaap Interest Paid Net
InterestPaidNet
15647 usd
CY2022 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
CY2021 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
CY2022Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
83588 usd
CY2022Q3 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 usd
CY2022Q3 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
398040 usd
CY2022Q3 us-gaap Customer Deposits Current
CustomerDepositsCurrent
1500 usd
CY2021 pnht Borrowed From Related Party
BorrowedFromRelatedParty
14250 usd
CY2021 us-gaap Interest Expense Other
InterestExpenseOther
4498 usd
CY2022 pnht Prepaid Wages Related Party
PrepaidWagesRelatedParty
1098 usd
CY2022 pnht Payroll Liabilities Related Party
PayrollLiabilitiesRelatedParty
7706 usd
CY2022Q3 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
398040 usd
CY2021Q3 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
363996 usd
CY2022Q3 pnht Effective Tax Rate
EffectiveTaxRate
0.21 pure
CY2022Q3 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
83588 usd
CY2021Q2 pnht Common Stock Issued
CommonStockIssued
2122000 shares
CY2021Q2 us-gaap Common Stock Value
CommonStockValue
201355 usd
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
39210000 shares
CY2022Q3 us-gaap Accounts Receivable Related Parties
AccountsReceivableRelatedParties
8332 usd
CY2022 pnht Payroll Expenses
PayrollExpenses
38214 usd

Files In Submission

Name View Source Status
0001640334-23-000027-index-headers.html Edgar Link pending
0001640334-23-000027-index.html Edgar Link pending
0001640334-23-000027.txt Edgar Link pending
0001640334-23-000027-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
pnht-20220731.xsd Edgar Link pending
pnht_10k.htm Edgar Link pending
pnht_ex311.htm Edgar Link pending
pnht_ex312.htm Edgar Link pending
pnht_ex321.htm Edgar Link pending
pnht_ex322.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
pnht-20220731_cal.xml Edgar Link unprocessable
pnht-20220731_pre.xml Edgar Link unprocessable
pnht-20220731_def.xml Edgar Link unprocessable
pnht-20220731_lab.xml Edgar Link unprocessable
pnht_10k_htm.xml Edgar Link completed